Argyrios G. Arvanitis

Author

Wilmington University

Also Known As

A Arvanitis, A. ARVANITIS, A. Arvanitis, A. G. ARVANITIS, Argyrios Arvanitis, Argyrios G. Arvanitis

Publications

674

Citations

H-Index

Concepts

All Affiliations

Wilmington University Bristol-Myers Squibb (United States)Experimental Station DuPont (United States)Bristol-Myers Squibb (Germany)

About

Argyrios G. Arvanitis is an author at Wilmington University specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	217
2	Natural Sciences	6	6	236
3	Biochemistry	6	6	237
4	Engineering	3	3	108
5	Social Sciences	1	1	15

Argyrios G. Arvanitis

Publications

654

Citations

H-Index

Page 1

	Year	Citations
Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans Adam D. Shilling, Frank M. Nedza, Thomas Emm, Drug Metabolism and Disposition	2010	107
Non-Peptide Corticotropin-Releasing Hormone Antagonists: Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines Argyrios G. Arvanitis, Paul J. Gilligan, Robert J. Chorvat, Journal of Medicinal Chemistry	1999	74
Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies C. Nicholas Hodge, Paul E. Aldrich, Zelda R. Wasserman, Journal of Medicinal Chemistry Crh1 Receptor AntagonistsReceptor-bound ConformationChemical BiologyMolecular PharmacologyMedicinal Chemistry	1999	69
Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines Robert J. Chorvat, Rajagopal Bakthavatchalam, James P. Beck, Journal of Medicinal Chemistry	1999	63
Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands Richard A. Hartz, Argyrios G. Arvanitis, Charles R. Arnold, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryBiochemistryMedicine	2005	63
Synthetic studies directed toward naturally occurring cyclooctanoids. 1. A total synthesis of (.+-.)-ceroplastol I. Robert K. Boeckman, Argyrios G. Arvanitis, Matthew E. Voss Journal of the American Chemical Society BiosynthesisEngineeringHeterocyclicBiochemistrySynthetic Studies	1989	59
A synthon for chiral glycolate enolate (rohcoor'): a camphor-based oxazoline T. Ross Kelly, Argyrios G. Arvanitis Tetrahedron Letters Chiral Glycolate EnolateEngineeringOrganic ChemistryStereoselective SynthesisChemistry	1984	39
In Vitro Intrinsic Clearance-Based Optimization of<i>N</i><sup>3</sup>-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Maria Rafalski, Journal of Medicinal Chemistry	2009	37
Synthesis, Structure−Activity Relationships, and In Vivo Evaluation of<i>N</i><sup>3</sup>-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF<sub>1</sub>) Receptor Antagonists Richard A. Hartz, Vijay T. Ahuja, Argyrios G. Arvanitis, Journal of Medicinal Chemistry	2009	32
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists James P. Beck, Argyrios G. Arvanitis, Matt A. Curry, Bioorganic & Medicinal Chemistry Letters Endocrine MechanismMedicinePhysiologyNeuroendocrine MechanismReceptor Antagonists	1999	27

Page 1